DK2897594T3 - Farmaceutisk sammensætning - Google Patents
Farmaceutisk sammensætning Download PDFInfo
- Publication number
- DK2897594T3 DK2897594T3 DK13771084.4T DK13771084T DK2897594T3 DK 2897594 T3 DK2897594 T3 DK 2897594T3 DK 13771084 T DK13771084 T DK 13771084T DK 2897594 T3 DK2897594 T3 DK 2897594T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12185339 | 2012-09-21 | ||
| EP13160799 | 2013-03-25 | ||
| PCT/EP2013/069570 WO2014044794A2 (en) | 2012-09-21 | 2013-09-20 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2897594T3 true DK2897594T3 (da) | 2020-06-29 |
Family
ID=49293599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13771084.4T DK2897594T3 (da) | 2012-09-21 | 2013-09-20 | Farmaceutisk sammensætning |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US10449158B2 (da) |
| EP (1) | EP2897594B1 (da) |
| JP (1) | JP6456830B2 (da) |
| CN (2) | CN104797243A (da) |
| CA (1) | CA2885278A1 (da) |
| DK (1) | DK2897594T3 (da) |
| ES (1) | ES2801801T3 (da) |
| WO (1) | WO2014044794A2 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10449158B2 (en) * | 2012-09-21 | 2019-10-22 | Ferring B.V. | Pharmaceutical activated carbon composition |
| US9682101B2 (en) | 2013-03-25 | 2017-06-20 | Ferring B.V. | Composition for the treatment of disease |
| CN105362496A (zh) * | 2015-06-13 | 2016-03-02 | 国网山东省电力公司临沂供电公司 | 一种用于治疗电力职工电光性眼炎的防护品 |
| US20180311278A1 (en) * | 2015-10-26 | 2018-11-01 | Daiichi Sankyo Company, Limited | Pharmaceutical preparation for delivery of porous material to large intestine or lower part of small intestine |
| WO2018063216A1 (en) * | 2016-09-29 | 2018-04-05 | M Pharmaceutical Usa Inc. | Dual compartment capsule for the administration of orlistat |
| GB2569119A (en) * | 2017-12-05 | 2019-06-12 | Rainbow Valley Nutrients Ltd | An aqueous beverage containing microencapsulated food supplement |
| US20210299170A1 (en) | 2018-08-05 | 2021-09-30 | Da Volterra | Method for improving anticancer agent efficacy |
| BR112021002105A2 (pt) | 2018-08-05 | 2021-06-01 | Da Volterra | composições para o tratamento da doença do enxerto contra hospedeiro |
| EP3610860A1 (en) * | 2018-08-15 | 2020-02-19 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Composition of carbon dioxide absorbent or adsorbent, whereby the said composition contains a polymeric coating selected from silicone rubber and cellulose |
| WO2023072929A1 (de) * | 2021-10-27 | 2023-05-04 | Rheinisch Westfälische Technische Hochschule (Rwth) Aachen | Umhüllte wirkstoffformulierung zu kontrollierten in vivo-aufnahme von co2 |
| DE102021127957A1 (de) | 2021-10-27 | 2023-04-27 | Rheinisch-Westfälische Technische Hochschule Aachen, Körperschaft des öffentlichen Rechts | Umhüllte Wirkstoffformulierung zu kontrollierten in vivo-Aufnahme von CO2 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5489010A (en) * | 1977-12-27 | 1979-07-14 | Kureha Chem Ind Co Ltd | Spherical activated charcoal antidote |
| IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
| US5843479A (en) * | 1993-02-26 | 1998-12-01 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| AU1075997A (en) * | 1996-11-15 | 1998-06-10 | Procter & Gamble Company, The | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| US6706263B2 (en) * | 1999-04-30 | 2004-03-16 | Kibow Biotech Inc. | Composition for alleviating symptoms of uremia in patients |
| US20040166248A1 (en) * | 2000-12-15 | 2004-08-26 | Sheng-Hsin Hu | Coated activated carbon |
| US7163696B2 (en) * | 2001-10-11 | 2007-01-16 | Pfizer Inc. | Pharmaceutical formulations |
| US8048413B2 (en) * | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| US8110186B2 (en) * | 2006-09-18 | 2012-02-07 | Chelatexx, LLC | Method to maintain the efficacy of orlistat |
| WO2008048469A2 (en) * | 2006-10-13 | 2008-04-24 | Actavis Group Pct Hf | Controlled-release coated dosage forms containing galantamine |
| US20090148538A1 (en) | 2007-10-12 | 2009-06-11 | Ocera Therapeutics, Inc. | Use of adsorbent carbon microspheres to treat pouchitis |
| RS54991B1 (sr) * | 2010-02-23 | 2016-11-30 | Da Volterra | Formulacije za oralnu isporuku adsorbenata u creva |
| TWI643623B (zh) | 2011-10-03 | 2018-12-11 | 菲瑞茵公司 | 用於瘻管之治療的組成物 |
| US10449158B2 (en) * | 2012-09-21 | 2019-10-22 | Ferring B.V. | Pharmaceutical activated carbon composition |
| US9682101B2 (en) * | 2013-03-25 | 2017-06-20 | Ferring B.V. | Composition for the treatment of disease |
-
2013
- 2013-09-20 US US14/429,806 patent/US10449158B2/en active Active
- 2013-09-20 CN CN201380060120.4A patent/CN104797243A/zh active Pending
- 2013-09-20 EP EP13771084.4A patent/EP2897594B1/en active Active
- 2013-09-20 ES ES13771084T patent/ES2801801T3/es active Active
- 2013-09-20 CA CA2885278A patent/CA2885278A1/en active Pending
- 2013-09-20 WO PCT/EP2013/069570 patent/WO2014044794A2/en active Application Filing
- 2013-09-20 DK DK13771084.4T patent/DK2897594T3/da active
- 2013-09-20 JP JP2015532423A patent/JP6456830B2/ja active Active
- 2013-09-20 CN CN201911389038.1A patent/CN111053759A/zh active Pending
-
2020
- 2020-12-10 US US17/117,599 patent/US11712422B2/en active Active
-
2023
- 2023-06-12 US US18/208,658 patent/US20240016753A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2897594A2 (en) | 2015-07-29 |
| ES2801801T3 (es) | 2021-01-13 |
| JP2015529233A (ja) | 2015-10-05 |
| US20210196647A1 (en) | 2021-07-01 |
| JP6456830B2 (ja) | 2019-01-23 |
| US20240016753A1 (en) | 2024-01-18 |
| WO2014044794A2 (en) | 2014-03-27 |
| WO2014044794A3 (en) | 2014-06-19 |
| US20150245999A1 (en) | 2015-09-03 |
| EP2897594B1 (en) | 2020-04-08 |
| US10449158B2 (en) | 2019-10-22 |
| CN104797243A (zh) | 2015-07-22 |
| US11712422B2 (en) | 2023-08-01 |
| CA2885278A1 (en) | 2014-03-27 |
| CN111053759A (zh) | 2020-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201700008B (it) | Composizione farmaceutica | |
| DK3181128T3 (da) | Farmaceutisk nilotinib-sammensætning | |
| DK2694038T3 (da) | Farmaceutisk sammensætning | |
| DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| BR112014003052A2 (pt) | composições farmacêuticas | |
| DK2825087T3 (da) | Otoscanner | |
| FR2997014B1 (fr) | Composition sterile dermo-injectable | |
| DK2839013T3 (da) | Ikke-disruptiv-gen-targetering | |
| BR112014032798A2 (pt) | composição | |
| DK2939692T3 (da) | Nasal influenzavaccinesammensætning | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| DE112012006109A5 (de) | Okklusionsschienenanordnung | |
| DK2854722T3 (da) | Stomipose | |
| CO6930367A2 (es) | Composiciones farmaceúticas | |
| ZA201501930B (en) | Pharmaceutical composition | |
| EE201300005A (et) | Ravimkoostis | |
| DK2897594T3 (da) | Farmaceutisk sammensætning | |
| EP2832730A4 (en) | MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION | |
| DK2825157T3 (da) | Aminosyrelipider | |
| DK2815752T3 (da) | Oral farmaceutisk sammensætning | |
| ES2721400T8 (es) | Composición de Diclofenaco | |
| CL2014003283A1 (es) | Formulación farmacéutica. | |
| DK2831122T3 (da) | Anthocyanidin-kompleks | |
| DE112012006214T8 (de) | Wulstringwickler |